BREAKING—analysis of Russian #SARSCoV2 vaccine’s phase 3 trial with ~ 20,000 participants finds that a 2-dose regimen has an efficacy of 91.6% against symptomatic #COVID19. No serious adverse events were deemed to be associated with vaccination. 100% efficacy for severe illness.
2) The benefits of the vaccine diverged from placebo around day ~18 after the first shot.

Estimated vaccine efficacy occurring at any time after dose 1 was 73·1% (95% CI 63·7–80·1). Notably, in vaccine group, most cases of #COVID19 occurred before dose 2
thelancet.com/journals/lance…
3) Notably, vaccine efficacy was 91·8% (67·1–98·3) in participants older than 60 years.

There were no cases (vaccine group) and 20 cases (placebo group) of moderate or severe COVID-19 confirmed at least 21 days after dose 1
4) From 15 to 21 days after the first dose, efficacy was 73·6% (p=0·048), then from day 21, efficacy was 100% (p<0·0001; appendix p 11).
5) presence of antibodies specific to the receptor-binding domain of SARS-CoV-2 42 days from the start of vaccination: In the vaccine group, RBD-specific IgG was detected in 336 (98%) of 342 samples—an antibody seroconversion rate of 98.25% in vaccinated!
6) serum samples from 100 participants were analysed for the presence of **neutralizing antibodies** on day 42 after first vaccination (figure 3B)—the neutralizing antibody seroconversion level was 95.83% in the vaccine group!
7) Sputnik V vaccine is a two-dose adenoviral vector vaccine using *two different adenoviruses* for each dose, administered 21 days apart. an adenovirus is altered so that it can deliver gene for spike protein. It's an similar to vaccines by AZ and J&J.
cnn.com/2021/02/02/hea…
8) But... The authors say that using a different adenovirus vector for the booster vaccination may help create a more powerful immune response. That’s what 🇷🇺 vaccine did.

Oxford / AZ meanwhile used same adenovirus for both first and second doses. That might explain somewhat.
9) One advantage of adenoviral vaccines is that they do not need to be stored and transported in extremely cold temperatures, scientists say. Sputnik V costs roughly $10 per dose, says CNN piece.
10) Time to update the table — another 15,000 vaccinated in Sputnik V trial with zero deaths.
11) Here is meantime the new Oxford-AZ vaccine report for 1 dose efficacy starting day 22–which found 76% for symptomatic #COVID19. See 🧵 for details.
12) I would next like to see data in the Russian Sputnik V vaccine and effects on pregnancy and if antibodies carry over into infants to protect them like this study did.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Eric Feigl-Ding

Eric Feigl-Ding Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @DrEricDing

4 Feb
Florida. Notice all the elderly ladies at the grocery store checkout aisle with zero masks.

Welcome to @RonDeSantisFL’s Florida, plus no travel restriction to anywhere else in America. #COVID19
2) Meanwhile here is South Dakota’s governor— equally crazy Trump loyalist.
3) Naples Florida to be precise.
Read 4 tweets
4 Feb
VACCINE HYPOTHETICAL: If you want to get a vaccine, but Pfizer, Moderna, J&J, Oxford/AstraZeneca, & Novavax aren’t available to your country... which vaccine would you go for? (Assuming all get approval by a major country/WHO org)...
2) If none of the above... but another one isn’t available anywhere in the horizon... would you still refuse? If so, why?
3) Yes there are more vaccines but many are far off in the distance.

Please share this poll above (RT the top post) to get more responses. Thx.
Read 5 tweets
4 Feb
Fauci: “We have to be concerned about the mutants” 👀

He’s right on the concern for the #B117, #B1351, #P1. Plus the B117+E484K mutant combination is worrisome. #COVID19

2) Here are the mutations within each of the 3 standard variants. But the #B117 has also acquired the bad E484K mutation found in the SA and Brazil variants in a new B117 sublineage in Wales 🏴󠁧󠁢󠁷󠁬󠁳󠁿 and England. E484K is the bad one. Image
3) here is the detailed thread 🧵 of the new sublineage of B117 + E484K
Read 9 tweets
4 Feb
15 MINUTE RULE IS WRONG! When you watch the SuperBowl, remember it was saved because the NFL knew the 15 minutes + 6 ft rule was wrong. The #COVID19 gospel of ‘within six feet for more than 15 minutes’ wasn’t enough—and the NFL had the data to prove it.🧵 wsj.com/articles/super…
2) It was early October, and NFL had a problem. It wasn’t just that players and staff for Tennessee Titans were continuing to test positive in an outbreak that shook NFL’s season. It wasn’t even that the NFL was learning that virus was able to rush through holes in its protocols.
3) The NFL was slowly discovering something far deeper: a core tenet of Covid-19 transmission wisdom—how to define when individuals are in “close contact”—was just wrong.
Read 5 tweets
4 Feb
Fauci: “We have to be concerned about the mutants” 👀

He’s right for the #B117, #B1351, #P1, and the Frankenstein B117+E484K mutant combination is worrisome. #COVID19
2) Here are the mutations within each of the 3 standard variants. But the #B117 has also acquired the bad E484K mutation found in the SA and Brazil variants in a new B117 sublineage in Wales 🏴󠁧󠁢󠁷󠁬󠁳󠁿 and England. E484K is the bad one. Image
3) Here is more info on the Frankenstein like new special B117+E484K combo...
Read 8 tweets
4 Feb
BREAKING—Opioid drug pushing firm McKinsey has agreed to pay $573 million to settle investigations for its role that “turbocharged” opioid sales. McKinsey worked to drive sales of Purdue Pharma’s OxyContin amid opioid epidemic that led to 450,000 deaths.🧵
nytimes.com/2021/02/03/bus… Image
2) The firm has reached the agreement with attorneys general in 47 states, the District of Columbia and five territories.

The firm also worked with a number of opioid makers to band together to “defend against strict treatment” by the Food and Drug Administration.
3) McKinsey’s extensive work with Purdue included advising it to focus on selling lucrative high-dose pills, the documents show, even after the drugmaker pleaded guilty in 2007 to federal criminal charges that it had misled doctors and regulators about OxyContin’s risks.
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!